nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A clinicopathological study of nm23-H1 expression in classical Hodgkin’s lymphoma
|
Niitsu, N. |
|
|
19 |
11 |
p. 1941-1946 |
artikel |
2 |
Acute exacerbation of hemorrhagic rectocolitis during antiangiogenic therapy with sunitinib and sorafenib
|
Loriot, Y. |
|
|
19 |
11 |
p. 1975 |
artikel |
3 |
Analysis of factors influencing inclusion of 102 patients with stage III/IV Hodgkin's lymphoma in a randomized trial for first-line chemotherapy
|
Biasoli, I. |
|
|
19 |
11 |
p. 1915-1920 |
artikel |
4 |
A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer
|
Santoro, A. |
|
|
19 |
11 |
p. 1888-1893 |
artikel |
5 |
Association of the polymorphism of the CAG repeat in the mitochondrial DNA polymerase gamma gene (POLG) with testicular germ-cell cancer
|
Blomberg Jensen, M. |
|
|
19 |
11 |
p. 1910-1914 |
artikel |
6 |
Axillary recurrence in sentinel lymph node-negative breast cancer patients
|
Poletti, P. |
|
|
19 |
11 |
p. 1842-1846 |
artikel |
7 |
Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie
|
Al-Batran, S.-E. |
|
|
19 |
11 |
p. 1882-1887 |
artikel |
8 |
CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy
|
Ennishi, D. |
|
|
19 |
11 |
p. 1921-1926 |
artikel |
9 |
Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation
|
Bishop, M.R. |
|
|
19 |
11 |
p. 1935-1940 |
artikel |
10 |
Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST)
|
Crusius, J.B.A. |
|
|
19 |
11 |
p. 1894-1902 |
artikel |
11 |
Editorial Board
|
|
|
|
19 |
11 |
p. ii-iii |
artikel |
12 |
Fatal hemoptysis in a patient with breast cancer treated with bevacizumab and paclitaxel
|
Philippin-Lauridant, G. |
|
|
19 |
11 |
p. 1977-1978 |
artikel |
13 |
Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib
|
Lacouture, M.E. |
|
|
19 |
11 |
p. 1955-1961 |
artikel |
14 |
High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer
|
Mir, O. |
|
|
19 |
11 |
p. 1978-1980 |
artikel |
15 |
Influence of capecitabine absorption on its metabolites pharmacokinetics: a bioequivalence study
|
Chaigneau, L. |
|
|
19 |
11 |
p. 1980-1981 |
artikel |
16 |
Internet use for medical research among cancer patients and their relatives in Spain
|
López-Gómez, M. |
|
|
19 |
11 |
p. 1976-1977 |
artikel |
17 |
in this issue
|
|
|
|
19 |
11 |
p. 1819 |
artikel |
18 |
Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup phase III BIG 02-98 trial
|
Pestalozzi, B.C. |
|
|
19 |
11 |
p. 1837-1841 |
artikel |
19 |
Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases
|
Scheer, M.G.W. |
|
|
19 |
11 |
p. 1829-1835 |
artikel |
20 |
Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer
|
Suijkerbuijk, K.P.M. |
|
|
19 |
11 |
p. 1870-1874 |
artikel |
21 |
Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcome
|
Somlo, G. |
|
|
19 |
11 |
p. 1853-1859 |
artikel |
22 |
Mucositis in the treatment of haematological malignancies Ann Oncol 2008; 19 (Supplement 7): vii141–vii145, 2008
|
|
|
|
19 |
11 |
p. 1982 |
artikel |
23 |
Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study
|
Villalona-Calero, M.A. |
|
|
19 |
11 |
p. 1903-1909 |
artikel |
24 |
Opinions concerning euthanasia, life-sustaining treatment and acceleration of death: results of an Italian Association of Medical Oncology (AIOM) survey
|
Catania, C. |
|
|
19 |
11 |
p. 1947-1954 |
artikel |
25 |
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy
|
Hoffer, L.J. |
|
|
19 |
11 |
p. 1969-1974 |
artikel |
26 |
Platinum-based chemotherapy in triple-negative breast cancer
|
Sirohi, B. |
|
|
19 |
11 |
p. 1847-1852 |
artikel |
27 |
Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells
|
Esparís-Ogando, A. |
|
|
19 |
11 |
p. 1860-1869 |
artikel |
28 |
Table of Contents
|
|
|
|
19 |
11 |
p. iv-v |
artikel |
29 |
Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall survival
|
Ghaffari, S.H. |
|
|
19 |
11 |
p. 1927-1934 |
artikel |
30 |
Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions
|
Raynaud, C.M. |
|
|
19 |
11 |
p. 1875-1881 |
artikel |
31 |
The contribution of countries and world regions in productivity of oncological publication
|
Tas, F. |
|
|
19 |
11 |
p. 1962-1968 |
artikel |
32 |
The effects of surgery on tumor growth: a century of investigations
|
Demicheli, R. |
|
|
19 |
11 |
p. 1821-1828 |
artikel |
33 |
The risk of taking the part by the whole
|
Castro, E. |
|
|
19 |
11 |
p. 1975-1976 |
artikel |